About this trial
The goal of this study is to pilot test the feasibility of a mobile health clinical decision support tool called ALRITE for the diagnosis and management of acute lower respiratory illnesses in young children in Uganda. Asthma/wheezing illness, in particular, is underdiagnosed in this setting. The main questions the study aims to answer are:
* Are the intervention structure, processes, outcomes, and implementations strategies feasible to conduct in the desired settings? * Does ALRITE increase the diagnosis of wheezing illness among children seen at Ugandan health centers?
Researchers will compare outcomes before and after ALRITE deployment to healthcare workers at 4 Ugandan healthcare centers using an interrupted time series design. Study participants are healthcare workers.
There will be12 months of baseline data collection ("baseline period"), at the beginning of which healthcare workers will be enrolled at each site. Following the baseline period, health workers will receive ALRITE training and will be encouraged but not required to use ALRITE in clinical care for a 6-month intervention period. Health worker participants will fill out surveys and participate in focus group discussions to provide feedback.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Healthcare workers employed at each study site with a minimum of 6 months' experience of caring for children with respiratory symptoms in general outpatient care
Completed one of the following training programs: medical officer, clinical officer, nurse, midwife
proficient in reading and speaking English, one of the official languages of Uganda
at least 18 years of age
Disqualifiers
inability to read/write English
Trial design
Single group
Treatments tested in this trial
ALRITE
Other interventionALRITE is a point-of-care mobile health clinical decision support tool designed for use by healthcare workers in Uganda. ALRITE guides the user into entering patient information and provides guideline-concordant recommendations. ALRITE also includes educational videos and weight-based dosing.
Treatment groups
Trial outcomes
Primary outcomes
Healthcare worker enrollment (study feasibility)
Number of healthcare workers enrolled during the baseline phase and additional healthcare workers who were enrolled during the remaining study period (ex: new hires or transfers)
Healthcare worker retention (study feasibility)
Proportion of healthcare workers active in the study over total number enrolled
Availability of ALRITE-enabled devices (study feasibility)
Proportion of functional devices over number of devices provided to the facility per month
ALRITE training completion (study feasibility)
Number of ALRITE training sessions completed per site
Secondary outcomes
Diagnosis rate of wheezing illness
Diagnosis rates of wheezing illness/asthma among all young children presenting to study sites, as recorded in the health record
Diagnosis rate of pneumonia
Diagnosis rates of pneumonia among all young children presenting to study sites, as recorded in the health record
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Washington
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
This trial is not recruiting at the moment. You can still explore other options: